News|Articles|July 28, 2026

How Should You Respond to FDA 483 Observations?

Is FDA getting tired of writing warning letters? A new draft guidance shows how companies should respond to Form 483 observations.

In March, the Agency published a draft guidance on Responding to FDA Form 483 Observations.1 We will discuss it from a laboratory perspective, covering:

Related to this article

Best of the Week: From Olive Waste to mRNA Vaccines
This week's Chromatography Online highlights include olive waste antioxidant recovery, food and tea analysis, EV isolation, mRNA vaccine purification, perfusion chromatography for oligonucleotides, mass spectrometry in teaching and career advice from “Women in Chromatography.”